A new cluster of high-end medical device companies is rapidly taking shape in Beijing’s Changping district, underscoring China’s accelerating push toward technological self-reliance in healthcare.
At the center of this effort is the Champion Bio hub, which is emerging as a key platform for advanced medical equipment, precision medicine, and biotechnology innovation. The park is focusing on three core segments: high-end devices, high-value consumables, and advanced diagnostics.
The strategy reflects broader shifts in global healthcare — toward digitalization, intelligent systems, and personalized treatment.
Inside the cluster, a growing number of companies are translating academic research into commercial products.
One example is TowardPi Medical, whose core technologies originated from Tsinghua University. The company has developed a full portfolio of ophthalmic imaging systems, including optical coherence tomography (OCT) devices and surgical microscopes.
Over the past four years, its OCT systems have been installed in more than 1,000 units across China, achieving a leading domestic market position.
More notably, the company has begun expanding overseas — exporting to over 50 countries, including Germany, France, Italy, and Singapore.
“Our growth is driven by technological capability, not price competition,” said Wang Yingqi, cofounder of TowardPi Medical.
👉 Upgrade to Pro to unlock full analysis:
- Why China is targeting one of the most protected global industries
- How AI + medical devices could become a strategic breakthrough
- What this means for Western medtech leaders
🔒 China Signals
Beijing Is Building a Medical Tech Powerhouse — And Europe Is Already Buying In
What is happening in Beijing’s Changping district is not just an industrial upgrade.
It is an early-stage signal of China’s ambition to break into one of the most technologically complex — and globally protected — sectors: high-end medical devices.
this is standard content, view need get membership